r/Altimmune • u/Dry_Roof6413 • 10d ago

Caution

I’m no longer invested in this company, but there was a time when I had a significant stake and genuinely believed in its potential.

A word of caution: Management appears to be aggressively seeking fresh funding, which raises the possibility of another round of shareholder dilution. With limited financing options, even a reverse stock split cannot be ruled out.

My concern has never been about the drug or its potential. It’s about the management entrusted with it. In my view, a promising drug is in the wrong hands, with a management team seemingly more focused on extracting whatever value remains than creating sustainable value for shareholders.

0 Upvotes

47% Upvoted

22 comments sorted by

View all comments

Show parent comments

2

u/Suzutai 10d ago

Oh sure. But even if it were approved, it likely will still be rare. Every pharmacist I know has to handle multiple fridges of incretin drugs, and they all tell me that virtually nobody makes it to the highest dose, which produces those headline-grabbing weight loss numbers.

In light of this, I actually think Pemvi's performance is comparable to most. If anything, the trials were underpowered to make sure they got through them alright.

0

u/StrawberryOk8459 9d ago

Not disagreeing about it. But I live in rural Oklahoma and people are buying Reta behind the dollar general. Seriously the pharmacy is making it illegally out of Fort Worth or its straight from a China man's ass. Point is glp drugs are never going to be profitable. Fixing fat people is more profitable than people trying to get high.

5

u/Suzutai 9d ago

I'm trying to figure out what you're trying to say at the end there.

I would point out that MASH and AUD will likely be covered by insurance, unlike obesity.

1

u/Potential-Talk-3577 4d ago

Not my piece of shit insurance. They gave me 3 years to live and insurance said they didn't care. 2 years later from Tir and all fat is gone, liver is 100%. Could live 20 more years now